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Abstract 20 
In broiler chickens, feed additives, including prebiotics, are widely used to improve gut health and 21 
to stimulate performance. Xylo-oligosaccharides (XOS) are hydrolytic degradation products of 22 
arabinoxylans that can be fermented by the gut microbiota. In the current study it was aimed to 23 
analyze the prebiotic properties of XOS when added to the broiler diet. Administration of XOS to 24 
chickens, on top of a wheat/rye-based diet, significantly improved the feed conversion ratio. XOS 25 
significantly increased villus length in the ileum. It also significantly increased numbers of 26 
lactobacilli in the colon and Clostridium cluster XIVa in the caeca. Moreover, the number of gene 27 
copies encoding the key bacterial enzyme for butyrate production, butyryl-CoA:acetate CoA-28 
transferase, was significantly increased in the caeca of chickens administered XOS. In this group of 29 
chickens, at species level, Lactobacillus crispatus and Anaerostipes butyraticus were significantly 30 
increased in abundance in the colon and caecum, respectively. In vitro fermentation of XOS 31 
revealed cross-feeding between L. crispatus and A. butyraticus. Lactate, produced by L. crispatus 32 
during XOS fermentation, was utilized by the butyrate-producing Anaerostipes species. These data 33 
show the beneficial effects of XOS on broiler performance when added to the feed, which 34 
potentially can be explained by stimulation of butyrate-producing bacteria through cross-feeding of 35 
lactate and subsequent effects of butyrate on gastrointestinal function. 36 
Introduction 37 
Cereal fibers are composed of carbohydrate polymers that are resistant to digestion in the small 38 
intestine of monogastric animals but are completely or partially fermented in the distal gut, and are 39 
believed to stimulate gut health (1). The main components of the cereal fiber fraction are 40 
arabinoxylans (AX), pectins, resistant starch, cellulose, β-glucans and lignin (2). Hydrolytic 41 
degradation of the heteropolymer AX results in a mixture of arabinose substituted xylo-42 
oligosaccharides or arabinoxylan-oligosaccharides (AXOS) and non-substituted xylo-43 
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oligosaccharides (XOS) (3). XOS are oligomers consisting of xylose units, linked through β-(1-4) 44 
linkages (4). Selective fermentation of XOS has been shown to induce changes in both the 45 
composition and activity of the gastrointestinal microbiota, improving the health and well-being of 46 
the host. This suggests that XOS could fulfill the definition of a prebiotic (5). The production of 47 
lactate and short chain fatty acids (SCFA), including butyrate, upon fermentation of XOS, has been 48 
confirmed in several in vitro and in vivo studies (3, 6). Lactate can stimulate butyrate production 49 
due to cross-feeding between lactate-producing bacteria and lactate-utilizing butyrate-producing 50 
bacteria from Clostridium cluster XIVa (7). Butyrate has proven beneficial effects on 51 
gastrointestinal function, since it has anti-inflammatory properties, fuels epithelial cells and 52 
increases the intestinal epithelial integrity. In addition, butyrate has been shown to improve growth 53 
performance in production animals and to change the microbiota composition and metabolic 54 
activity of the microbial ecosystem in the intestine (8, 9).  55 
Beneficial effects of XOS have already been described in rats. In these studies, XOS was shown to 56 
significantly increase the bifidobacteria and lactobacilli population in the caecum (10, 11). An in 57 
vitro study using swine faecal microbiota showed the highest SCFA production during fermentation 58 
of XOS (12). To our knowledge, there is not much published research on the effect of XOS on the 59 
gastrointestinal health of chickens except for the recent publication of Zhenping et al.  (13), 60 
showing the increased growth performance, enhanced endocrine metabolism and improved immune 61 
function in broiler chickens after in feed supplementation of straw-derived XOS. However, the 62 
effect of XOS on the microbiota composition in broilers has not yet been described.  63 
In the broiler chicken, the distal ileum, the caeca and the colon are regarded as fermentation 64 
chambers whose function is determined by the microbiota composition (14, 15). The chicken gut 65 
microbiota is dominated by species belonging to the phyla Firmicutes (up to 75 %) and 66 
Bacteroidetes (between 10 % and 50 %) (16-22). Around 90 % of the bacteria in the chicken 67 
gastrointestinal tract are unknown species, indicating that the knowledge of the intestinal microbiota 68 
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of chickens is incomplete (23-24). The majority of sequences within the Firmicutes phylum belong 69 
to the families Ruminococcaceae and Lachnospiraceae, the so called Clostridium cluster IV and 70 
XIVa, respectively (25). Both families contain numerous members that are known to produce 71 
butyrate as a fermentation end product and are therefore linked to beneficial effects on 72 
gastrointestinal function (26, 27). Whether the abundance of these groups in the distal gut of 73 
chickens is affected by XOS is unclear.  74 
In the current study, we analyzed the effect of XOS administration on the performance of broilers. 75 
In addition, we aimed to identify the shifts in microbiota composition induced by XOS to explain 76 
possible beneficial effects on gastrointestinal health, with emphasis on butyrate production.  77 
Materials and Methods 78 
Additives/substrates 79 
In the in vivo study corncob-derived XOS35 (Longlive Bio-technology, Shandong, China) was used 80 
as feed additive. XOS35 is a mixture of 35 % XOS with a degree of polymerization (DP) between 81 
2-7 and 65% maltodextrin. In the in vitro fermentation study XOS35, maltodextrin (Sigma-Aldrich, 82 
St. Louis, United States) and XOS95 (Longlive Bio-technology, Shandong, China), a mixture of 95 83 
% XOS with DP 2-7 and 5 % xylose, were used. The XOS95 and maltodextrin were used be 84 
confirm that the effects of XOS35 in the in vivo trial were explained by the XOS.  85 
Animals and diets 86 
A total of 192 male and 192 female one-day-old Ross-308 broiler chickens were randomly divided 87 
in 12 pens (3 pens of female and 3 pens of male birds per treatment and 32 chickens per pen) and 88 
housed on solid floor covered with wood shavings. Light schedule was set to provide an 18h 89 
light/6h dark cycle. The infrared bulbs (1 per pen during the first week) together with the central 90 
heating system provided optimal temperature. All animals were fed a wheat/rye-based diet with 91 
XOS (experimental group) or without XOS (control group) of which the composition is shown in 92 
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Table 1. The experimental starter feed (fed from the first day of age until day 13) was supplemented 93 
with 0.2 % XOS, the grower feed (fed from day 14 until day 26) and the finisher feed (fed from day 94 
27 until day 39) were supplemented with 0.5 % XOS. At 13, 26 and 39 days of age, all broilers and 95 
the feed leftovers were weighed per pen to calculate the feed conversion ratio (FCR), weight gain 96 
(WG) and feed intake (FI). At 26 days of age, three chickens per pen were euthanized by an 97 
intravenous overdose of sodium pentobarbital 20% (Kela, Hoogstraten, Belgium). The complete 98 
content of caecum and colon was collected and stored at -70°C, while a part of the ileum at the level 99 
of Meckel’s diverticulum was fixed in 4% formaldehyde.  100 
Morphological examination  101 
Formalin fixed ileum segments taken at the level of Meckel’s diverticulum were dehydrated in 102 
xylene, embedded in paraffin and sectioned in 4 µm slides. The sections were deparaffinized (2 x 5 103 
min) in xylene, rehydrated in isopropylene (5 min), 95 % alcohol (5 min) and 50 % alcohol (5 min) 104 
and stained with haematoxylin and eosin. The sections were examined using light microscopy. 105 
Villus length and thickness of tunica muscularis were measured by random measurement of 10 villi 106 
and 10 measurements of tunica muscularis per section using Leica DM LB2 Digital (Leica 107 
Microsystems Belgium BVBA, Diegem, Belgium) and a PC-based image  analysis system, 108 
LAS V3.8 (Leica application Suit V3, Diegem Belgium).  109 
Microbiota composition 110 
DNA extraction 111 
DNA was extracted from caecum and colon content using the CTAB method as described 112 
previously (29, 30). To 100 mg of intestinal content, 0.5 g unwashed glass beads (Sigma-Aldrich, 113 
St. Louis, United States), 0.5 ml CTAB buffer (hexadecyltrimethylammonium bromide 5 % (w/v), 114 
0.35 M NaCl, 120 mM K2HPO4) and 0.5 ml phenol-chloroform-isoamyl alcohol mixture (25:24:1) 115 
(Sigma-Aldrich, St. Louis, United States) were added followed by homogenization in a 2 ml 116 
destruction tube. The samples were shaken 6 times for 30 seconds using a beadbeater (MagnaLyser, 117 
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Roche, Basel, Switzerland) at 6000 rpm with 30 seconds between shakings. After centrifugation (10 118 
min, 8000 rpm), 300 µl of the supernatant was transferred to a new tube. The rest of the tube 119 
content was re-extracted with 250 µl CTAB buffer and again homogenized with a beadbeater. The 120 
samples were centrifuged for 10 minutes at 8000 rpm and 300 µl supernatant was added to the first 121 
300 µl supernatant. The phenol was removed by adding an equal volume of chloroform-isoamyl 122 
alcohol (24:1) (Sigma-Aldrich, St. Louis, United States) and a short spin. The aqueous phase was 123 
transferred to a new tube. The nucleic acids were precipitated with two volumes of PEG-6000 124 
solution (polyethyleenglycol 30 % (w/v), 1.6 M NaCl) for two hours at room temperature. After 125 
centrifugation (20 min, 13000 rpm), the pellet was rinsed with one ml of ice-cold 70 % (v/v) 126 
ethanol. The pellet was dried and resuspended in 100 µl RNA free water (VWR, Leuven, Belgium).  127 
Quantitative PCR for the total bacteria and the butyryl-CoA:acetate-CoA transferase gene  128 
The number of total bacteria and butyryl-CoA:acetate-CoA transferase genes was quantified in 3 129 
samples per pen (18 samples per treatment). To determine the number of total bacteria, primers Uni 130 
331F (5’-TCCTACGGGAGGCAGCAGT-3’) and Uni 797R (5’-131 
GGACTAACCAGGGTATCTAATCCTGTT-3’) were used (31). Amplification and detection was 132 
performed using the CFX384 BioRad detection system (BioRad, Nazareth-Eke, Belgium). Each 133 
reaction was done in triplicate in a 12 µl total reaction mixture using 2x SensiMix™ SYBR No-134 
ROX mix (Bioline, Kampenhout, Belgium), 0.5 µM final primer concentration and 2 µl of (50 135 
ng/µl) DNA. The amplification program consisted of 1 cycle at 95 °C for 10 min followed by 40 136 
cycles of 1 min at 94 °C, 1 min at 53°C and 2 min at 60 °C. The fluorescent products were detected 137 
at the last step of each cycle. A melting curve analysis was done after amplification and was 138 
obtained by slow heating from 60 °C to 95 °C at a rate of 0.5 °C/5 sec to confirm the specificity of 139 
the reaction.  140 
To quantify the number of gene copies encoding the butyryl-CoA:acetate-CoA transferase enzyme 141 
primers BCoATscrF (5’-GCIGAICATTTCACITGGAAYWS-3’) and BCoATscrR (5’-142 
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CCTGCCTTTGCAATRTCIACRA ANGC-3’) were used (32). Each reaction was done in triplicate 143 
in a 12 µl total reaction mixture using 2x SensiMix™ SYBR No-ROX mix (Bioline, Kampenhout, 144 
Belgium), 2.5 µM final primer concentration and 2 µl of (50 ng/µl) DNA. The amplification 145 
program consisted of 1 cycle at 95 °C for 10 min followed by 40 cycles of 30 sec at 95 °C, 30 sec at 146 
53 °C and 30 sec at 72 °C.  147 
16S sequencing to identify microbiota composition 148 
Faecal samples derived from one animal per pen (6 per treatment) were used for 16S sequencing. 149 
For each sample, 16S rDNA PCR libraries were generated with the primers E9-29 and E514-430 150 
(33) targeting hypervariable regions V1-V3. The oligonucleotide design included 454 Life 151 
Sciences’s A or B sequencing titanium adapters (Roche Diagnostics, Vilvoorde, Belgium) and 152 
multiplex identifiers (MIDs) fused to the 5’ end of each primer. The amplification mix contained 5 153 
U of FastStart high fidelity polymerase (Roche Diagnostics, Vilvoorde, Belgium), 1x enzyme 154 
reaction buffer, 200 µM dNTPs (Eurogentec, Liège, Belgium), 0.2 µM of each primer and 100 ng 155 
of genomic DNA in a volume of 100 µl. Thermocycling conditions consisted of a denaturation at 94 156 
°C for 15 min followed by 25 cycles at 94 °C for 40 s, 56 °C for 40 s, 72 °C for 1 min and a final 157 
elongation step of 7 min at 72 °C. These amplifications were performed on an Ep Master System 158 
gradient apparatus (Eppendorf, Hamburg, Germany). Electrophoresis of the PCR products was done 159 
on a 1 % agarose gel and the DNA fragments were plugged out and purified using the SV PCR 160 
purification kit (Promega Benelux, Leiden, The Netherlands). The quality and quantity of the 161 
products were assessed with a Picogreen dsDNA quantitation assay (Isogen, St-Pieters-Leeuw, 162 
Belgium). All libraries were run in the same titanium pyrosequencing reaction using Roche MIDs. 163 
All amplicons were sequenced using the Roche GS-Junior Genome Sequencer instrument (Roche, 164 
Vilvoorde, Belgium), the sequence number of each sample is normalized to 2323 reads.  165 
The 16S rDNA sequence reads were processed with the MOTHUR package (34). The quality of all 166 
sequence reads were denoised using the Pyronoise algorithm implemented in MOTHUR and 167 
filtered with the following criteria: minimal length of 425 bp, an exact match to the barcode and 1 168 
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mismatch allowed to the proximal primer. The sequences were evaluated for the presence of 169 
chimeric amplifications using Uchime (35). The resulting read sets were compared to a reference 170 
dataset of aligned sequences of the corresponding region derived from the SILVA database 1.15 of 171 
full-length rDNA sequences (http://www.arb-silva.de/) implemented in MOTHUR (36). The final 172 
reads were clustered into operational taxonomic units (OTUs) using the nearest neighbour 173 
algorithm using MOTHUR with a 0.03 distance unit cut-off. At the OTU level of analysis (OTU 174 
definition level for a 0.02 distance matrix), a total of 3052 OTUs were created. A taxonomic 175 
identity was attributed to each OTU by comparison with the SILVA database (80 % homogeneity 176 
cut-off). As a secondary analysis all unique sequences for each OTU were compared to the SILVA 177 
dataset 1.15 using BLASTN algorithm (37). For each OTU, a consensus detailed taxonomic 178 
identification was given based upon the identity (less than 1 % of mismatch with the aligned 179 
sequence) and the metadata associated with the best hit (validated bacterial species or not). The raw 180 
sequences were deposited in Genbank (accession number: PRJNA277118).  181 
In vitro fermentation 182 
Bacterial strains, growth and co-culture studies 183 
The butyrate-producing strain Anaerostipes butyraticus LMG 24724T and the lactate producing 184 
strain Lactobacillus crispatus LMG 9479T were purchased from the LMG culture collection. A. 185 
butyraticus and L. crispatus were grown in M2GSC (38) and Man-Rogosa-Sharpe (MRS) medium, 186 
respectively, in an anaerobic chamber (Ruskinn technology, Bridgend, United Kingdom) with 84 % 187 
N2, 8 % H2 and 8 % CO2 at 37 °C.  188 
The in vitro fermentation study was conducted using a nutrient-poor medium described by Moura et 189 
al. (39) with minor modifications (0.85 g/l casitone, 0.15 g/l enzymatic digest of soya bean, 0.25 g/l 190 
NaCl, 0.125 g/l K2HPO4, 5.0g/l bactopeptone, 5.0 g/l yeast nitrogen base and 0.5g/l resazurin. After 191 
autoclaving 1 mg/ml cysteine-HCl, 1 % (v/v) of salt solution A (100.0 g/l NH4Cl, 10.0 g/l 192 
MgCl2.6H2O, 10.0 g/l CaCl2.2H2O), 1 % (v/v) trace solution (0.025 g/l MnCl2.4H2O, 0.02 g/l 193 
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FeSO4.7H2O, 0.025 g/l ZnCl2, 0.025 g/l CuCl2.2H2O, 0.05 g/l CoCl2.6H2O, 0.05 g/l SeO2, 0.25 g/l 194 
NiCl2.6H2O, 0.25 g/l Na2MoO4.2H2O, 0.314 g/l NaVO3, 0.25 g/l H3BO3 dissolved in 0.02M HCl) 195 
and 1.2 % (v/v) vitamin/phosphate solution (0.0204 g/l biotin, 0.0205 g/l folic acid, 0.164 g/l Ca D-196 
pentothenate, 0.164 g/l nicotinamide, 0.164 g/l riboflavin, 0.164 g/l thiamin HCl, 0.164 g/l 197 
pyridoxine HCl, 0.201 g/l para-amino benzoid acid, 0.0205 g/l cyanocobalamin dissolved in 54.7 198 
g/l KH2PO4, filter sterile)) containing a mixture of SCFAs (final concentrations: acetate (31mM); 199 
propionate (9mM); isobutyrate, isovalerate and valerate (1mM each)). A 5 % stock solution of 200 
XOS35, maltodextrin and XOS95 was prepared in the nutrient-poor medium, filter-sterilized (0.2 201 
µm), and diluted in the nutrient-poor medium to a final concentration of 0.5 % (v/v). Un-202 
supplemented nutrient-poor medium was used as control (blank). The final pH of the medium was 203 
adjusted to 6.5 ± 0.1. The media were pre-incubated in an anaerobic cabinet until anaerobiosis, as 204 
indicated by the colorless state of resazurin in the media. A. butyraticus and L. crispatus, pre-205 
cultured in M2GSC and MRS broth, respectively, at 37 °C under anaerobic conditions for 24 ± 1 h 206 
without shaking, were diluted 100-fold in the supplemented and non-supplemented nutrient-poor 207 
medium. The co-culture of A. butyraticus and L. crispatus was prepared using equal portions of the 208 
inoculum (2 times 1/200) from the 2 pure cultures. After 24 h anaerobic incubation at 37 °C, 209 
bacterial growth was monitored by measuring the optical density at 650 nm. After measuring the 210 
pH, the cultures were centrifuged at 14000 rpm for 10 min at room temperature. The supernatants 211 
were stored at -20 °C until lactate and butyrate concentrations were determined using high-212 
performance liquid chromatography (HPLC) analysis. The in vitro fermentation assay was done 213 
twice in triplicate.  214 
Determination of butyrate and lactate concentrations 215 
DL-lactate and butyrate were quantified using HPLC with ultraviolet detection, as described by De 216 
Baere et al. (40). The supernatant was acidified using concentrated hydrochloric acid and extracted 217 
with diethyl ether for 20 min. The upper ether phase was transferred to another extraction tube and 218 
extracted again for 20 min with sodium hydroxide. The aqueous phase was transferred to an 219 
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autosampler vial and concentrated hydrochloric acid was added. An aliquot was injected on the 220 
HPLC-UV instrument. The HPLC instrument consisted of a P1000X type quaternary gradient 221 
pump, an AS3000 type autosampler, an UV1000 type ultraviolet detector and a SN4000 type 222 
system controller, all from ThermoFisher Scientific (Breda, The Netherlands). Chromatographic 223 
separation was achieved using a hypersilGold aQ column (150 x 4.6 mm, particle size: 3 µm, 224 
ThermoFisher Scientific). Gradient elution (80/20) was performed using NaH2PO4 in HPLC grade 225 
water and HPLC grade acetonitrile as mobile phase A and B, respectively. The detector was set at a 226 
wavelength of 210 nm. The Chromquest software (ThermoFisher Scientific) was used for data 227 
processing.  228 
Statistical analysis 229 
The comparison of the performance data was performed with an independent samples t-test (SPSS 230 
22.0). For the qPCR and morphology data were analyzed by means of a linear mixed effect model 231 
with pen included as random effect (S-Plus). The differences were considered statistically 232 
significant at P value ≤ 0.05 and considered as a tendency at P ≤ 0.1. Statistical differences in 233 
relative abundance in bacterial population between groups were assessed by non-parametric 234 
Kruskal-Wallis H test with Benjamin-Hochberg False Discovery Rate screen and Tukey-Kramer 235 
post-hoc test. Moreover, differences in specific bacterial population relative abundance based on 236 
16S profiling were analyzed with non-parametric Mann-Whitney test using a two-tailed P value 237 
calculation. GraphPad Prism software version 5 was used to perform the statistical analysis for the 238 
in vitro fermentation. All quantitative parameters (pH, OD, SCFA concentrations) were compared 239 
using the Kruskal-Wallis test. The Dunns post hoc test was applied for multicomparisons of these 240 
variables if there was a significant difference with the Kruskal-Wallis test.  241 
Results 242 
Broiler performance after supplementation of broiler feed with XOS35  243 
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To evaluate the effect of XOS on broiler performance, the body weight and feed intake were 244 
measured and FCR and growth were calculated. When considering the starter and grower period 245 
together (day 0 to day 26), the FCR was significantly (P = 0.003) more favorable for chickens fed 246 
the XOS-supplemented diet compared to the chickens fed the control diet (Table 2). For the whole 247 
trial period (day 0 – 39), the FCR was also significantly improved (lower) for the group receiving 248 
the XOS-supplemented diet (P = 0.04). The average body weight at the different time points was 249 
non-significantly higher for chickens fed the diet supplemented with 0.5 % XOS compared to the 250 
chickens given the non-supplemented diet. These results together with the significantly improved 251 
FCR show a biologically relevant improved performance for chickens given the XOS-supplemented 252 
diet.  253 
Intestinal morphology  254 
Supplementation of 0.5 % XOS to the broiler feed significantly (P = 0.04) increased the villus 255 
length in the ileum (Table 3). The tunica muscularis was shown (P = 0.38) to be thicker in the 256 
group fed the XOS-supplemented diet (Table 3). 257 
Microbiota composition as determined by qPCR and 16S sequencing 258 
There was no difference in the number of total bacteria between the XOS-supplemented and non-259 
supplemented group in both the caecum and the colon (Fig. 1A). The number of gene copies 260 
encoding the butyryl-CoA:acetate-CoA transferase was significantly (P = 0.02) higher in the caeca 261 
of the chickens that received 0.5 % XOS (Fig. 1B).  262 
Significant changes were observed in the abundance of specific 16S sequences in caecum and colon 263 
samples at different taxonomic levels (Fig. 2, Table 4). Although 35 bacterial families were 264 
detected in the caecal microbiota, only the abundance of Clostridium cluster XIVa was shown to be 265 
significantly (P = 0.005) increased in animals fed a XOS-supplemented diet as compared to animals 266 
fed a control diet (44.29% vs 29.65%, Table 4). Forty one bacterial families were detected in the 267 
colon microbiota of which Lactobacillaceae was shown to be significantly (P = 0.033) higher in 268 
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animals fed a XOS-supplemented diet compared to animals fed a control diet (81.54% vs 41.73%). 269 
In the caecal samples a total of 834 species were detected of which 16 were shown to be 270 
significantly different between the XOS treated and control animals. A significant higher abundance 271 
was observed for Anaerostipes butyraticus, a butyrate producing species classified within 272 
Clostridium cluster XIVa (from 0.4 % to 2.5 %, P = 0.048, Fig. 2). Seven hundred twenty one 273 
species were detected in the colon samples of which 11 were shown to be significantly different in 274 
animals receiving dietary XOS compared to control diet. XOS supplementation resulted in a 275 
significant increase of Lactobacillus crispatus (from 4 % to 15 %, P = 0.007, Fig. 2) in the colon. 276 
In vitro fermentation 277 
To investigate cross-feeding between L. crispatus and A. butyraticus in the presence of XOS, an in 278 
vitro fermentation assay was carried out. XOS95 and maltodextrin were used to confirm the effect 279 
of XOS in the in vivo trial. Only the monoculture of L. crispatus resulted in a small pH drop when 280 
XOS35 was added to the medium (6.4 ± 0.04 versus 6.2 ± 0.04, Fig. 3). A. butyraticus showed a 281 
significantly increased (P = 0.007) proliferation when XOS35 and XOS95 were added to the 282 
medium compared to maltodextrin (Fig. 3). The proliferation of L. crispatus increased significantly 283 
when XOS35 was added to the medium. The proliferation of the strains in the co-culture was higher 284 
when XOS35 or XOS95 was added compared to the non-supplemented media (Fig. 3). 285 
Supplementation of maltodextrin to the medium did not cause any changes. 286 
The concentrations of the fermentation acids butyrate and DL-lactate were determined after 287 
incubation, in all monocultures and co-cultures (Fig. 4). It was found that A. butyraticus was able to 288 
produce butyrate, while L. crispatus produced high concentrations of lactate. The concentration of 289 
butyrate or lactate produced by L. crispatus and A. butyraticus, respectively, were below the cut-off 290 
values (1mM and 0.5 mM respectively) as determined during optimization of the HPLC method 291 
(40). XOS35 and XOS95 significantly stimulated lactate production by L. crispatus compared with 292 
A. butyraticus, which was not able to produce lactate. In the co-culture, lactate concentrations were 293 
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very low, even when XOS35 or XOS95 were added to the medium, while the butyrate 294 
concentration was higher as compared to the concentrations in the monoculture of A. butyraticus 295 
with XOS35 (3.3 ± 0.8 versus 2.3 ± 0.6, Fig. 4), but non-significant. A similar observation was 296 
made for XOS95 (2.4 ± 0.8 versus 1.6 ± 0.6).   297 
Discussion 298 
It is generally accepted that shifts in the intestinal microbiota composition may be the result of 299 
dietary changes, such as the addition of cereal fibres (22, 41,42). In the current study, we 300 
demonstrated that administration of XOS to broiler feed altered the microbiota composition in the 301 
gut, with butyrate-producing bacteria and lactobacilli being more abundant in caeca and colon, 302 
respectively.  303 
In the chicken gut, lactobacilli are one of the predominant genera (43). These bacteria have the 304 
ability to adhere to the mucosal layers and epithelium, promoting colonisation (44, 45). Through 305 
interaction with the intestinal epithelial cells, lactobacilli can cause immunomodulation and offer 306 
protection to the intestinal barrier by antagonistic activities against pathogens (45-47). In addition, 307 
the probiotic use of lactobacilli has been shown to beneficially affect performance in broilers. 308 
Broilers fed diets containing a mixture of 12 Lactobacillus strains or a single Lactobacillus 309 
acidophilus strain had a better weight gain and a better FCR (48, 49). Lactobacilli are known to 310 
ferment carbohydrates into lactic acid as major end-product which may lower the pH of the 311 
intestinal environment resulting in the inhibition of growth of acid-sensitive pathogenic bacteria. 312 
However, this pH effect may be rather limited as lactic acid is absorbed from the intestine or used 313 
as a substrate for lactate-utilizing bacteria, such as representatives of the genera Eubacterium, 314 
Anaerostipes, Veillonella and Megasphaera (50, 51). 315 
In the present study, in addition to the significant higher abundance of lactobacilli in the colon, we 316 
found an increased number of butyryl-CoA:acetate CoA-transferase gene copies in the caeca of 317 
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chickens that received a XOS supplemented diet. Butyryl-CoA:acetate CoA-transferase is a key 318 
enzyme in the major pathway for bacterial butyrate production in the gut (7). Hippe et al. showed 319 
that this enzyme is a suitable marker for the butyrate producing capacity of the intestinal microbiota 320 
which mainly belong to Clostridium cluster IV and XIVa (52),(53). We observed a significant 321 
increase of members from both clusters in the caeca of chickens that were administered XOS.  322 
The increased abundance of both lactobacilli and butyrate-producing bacteria can partly be 323 
explained by cross-feeding mechanisms. Bacteria related to Eubacterium hallii and Anaerostipes 324 
caccae, both members of Clostridium cluster XIVa, are able to convert acetate and lactate into 325 
butyrate (7, 54). This metabolic cross-feeding between lactate producing and lactate utilizing 326 
bacteria may help to stabilize the luminal pH and may be a factor in the butyrogenic effect of 327 
certain dietary substrates (55). Our in vivo study showed a significant increase of the lactate 328 
producing species Lactobacillus crispatus in the colon and the lactate-utilizing butyrate-producing 329 
species Anaerostipes butyraticus in the caeca. The lactic acid produced by L. crispatus in the colon 330 
may reach the caecum and become available for A. butyraticus due to antiperistalsis (56, 57). The in 331 
vitro fermentation assay showed that reference strains of both species metabolized XOS resulting in 332 
production of high concentrations of lactic acid by L. crispatus, which were supposed to be 333 
consumed by the butyrate-producing bacterium A. butyraticus. Most likely also many other strains 334 
can carry out a similar cross-feeding reaction in order to generate high butyrate levels in the chicken 335 
hindgut.  336 
Production of butyrate most probably plays a role in the beneficial effects on gut morphology and 337 
growth performance observed in the current study. In poultry, butyrate enhances non-specific 338 
intestinal defence mechanisms against pathogens that can affect performance, such as Clostridium 339 
perfringens, by stimulating the mucin glycoprotein expression in intestinal epithelial cells (58-60). 340 
Butyrate is a major energy source for the colonocytes and exerts anti-inflammatory activities by 341 
several mechanisms (61). One of these mechanisms is the suppression of nuclear factor kappa B 342 
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(NF-κB) that regulates the expression of pro-inflammatory cytokines (62). Butyrate has also been 343 
shown to interfere with signalling by interferon-γ (IFN- γ) through its inhibitory effect on the 344 
activation of signal transducer and activator of transcription 1 (STAT1) (63). Butyrate also 345 
upregulates the expression of peroxisome proliferator-activated receptor-γ (PPAR-γ), a transcription 346 
factor that belongs to the nuclear hormone receptor family. PPAR-γ inhibits the expression of 347 
inflammatory cytokines and directs the differentiation of immune cells towards anti-inflammatory 348 
phenotypes (64-66).  349 
We observed longer villi in the ileum of chickens that were fed a XOS-supplemented diet as 350 
compared to chickens fed a control diet. This effect on the small intestinal morphology may at least 351 
partly be due to butyrate production by Clostridium cluster IV and XIVa species in the hindgut 352 
through its effect on the expression of glucagon-like peptide-2 (GLP-2). Butyrate indeed appears to 353 
be a strong stimulator of GLP-2 production. This hormone is secreted by entero-endocrine L-cells 354 
and acts indirectly through multiple downstream mediators (67). Its receptor (GLP-2R) is localized 355 
on distinct subpopulations of gut endocrine cells in the stomach, small intestine, and colon but also 356 
on subepithelial myofibroblasts (68, 69). Hu et al. showed a beneficial effect of intravenous GLP-2 357 
injection in broilers on growth performance, intestinal morphology, villi height and crypt cell 358 
proliferation (70).  359 
In conclusion, XOS, supplemented to the broiler diet, improved broiler performance by improving 360 
the feed conversion ratio. Administration of XOS resulted in an increased abundance of butyrate-361 
producing bacteria in the caeca and lactobacilli in the colon at day 26 of age. It is hypothesized that 362 
microbial cross-feeding, in which lactic acid produced by the lactobacilli is consumed by butyrate-363 
producing bacteria in the caeca stimulates gut heath and consequently performance, through the 364 
beneficial effects of butyrate. Whether this cross-feeding also occurs in the complex gut ecosystem, 365 
needs to be clarified in further in vivo work. 366 
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TABLE 1: The composition and nutrient content of the wheat/rye diet administered to chickens. Starter diet was given from day 1 582 
until 13, grower was given from day 14 until 26 and finisher was given from day 27 until 39.  583 
TABLE 2: The effect of XOS supplementation on the growth performance of the chickens. Feed conversion ratio (FCR), body 584 
weight (BW), feed intake (FI) and weight gain (WG) were measured at three time intervals for animals fed a wheat/rye-based diet 585 
without or with supplemented with 0.2% XOS (day 1-13) and 0.5% XOS (day 14-26; 27-39). Values are the mean of 6 pens with 32 586 
chickens ± standard error of the mean and n is the number of the chickens in each group. Statistical analysis was done with SPSS. 587 
Independent samples t-test was used to determine statistical differences between groups receiving non-supplemented and XOS 588 
supplemented diet. P-values less than 0.05 and 0.001 were considered significant (*, **).  589 
TABLE 3: The effects of XOS supplementation on the intestinal morphology of chickens on day 26. The data shown are the mean 590 
length of the villi (µm) and mean thickness of the tunica muscularis (µm) in ileal sections taken at day 26 of animals fed a wheat/rye-591 
based diet, without or with supplemented with 0.5 % XOS (n=18). The length and the thickness were measured of 10 randomly 592 
selected villi and 10 different places for the tunica muscularis using a PC-based analysis system. Statistical analysis was done with 593 
S-plus, using a linear mixed effects model with pen as random factor. P-value less than 0.05 were considered significant. 594 
TABLE 4: List of Clostridium cluster XIVa and cluster IV members identified in the caeca of chickens at day 26 of which the 595 
relative proportion was significantly different between the XOS supplemented and unsupplemented group. The results are based on 596 
the sequencing data of 6 chickens per treatment (ns, not significant).  597 
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Figures 598 
FIGURE 1: Number of total bacteria (A) and butyryl-CoA:acetate-CoA transferase gene copies (B) expressed as log10 copy number 599 
of the gene per g of wet content in the caecal and colonic content of 26-day old chickens fed a wheat/rye-based diet either or not 600 
supplemented with 0.5% XOS (18 chickens for each treatment). Statistical analysis is done with S-plus using a linear mixed effects 601 
model with pen as random factor to determine statistical difference between groups of animals fed a wheat/rye- based diet without 602 
and with XOS. * P ≤ 0.05 603 
FIGURE 2: Box plots showing mean relative sequence abundance of the Clostridium cluster XIVa and Anaerostipes butyraticus in 604 
the caecum (A) and of the Lactobacillaceae and Lactobacillus crispatus in the colon (B) of 26-day old chickens fed without or with 605 
XOS-supplemented feed (6 chickens for each treatment). The plus represents the mean value and the whiskers are the median, the 606 
min/max value and 1ste/3rd quartiles.  607 
FIGURE 3: pH values and optical densities (650 nm) after 24 h of in vitro fermentation of different substrates by A. butyraticus, L. 608 
crispatus and both in co-culture. All the in vitro fermentation experiments were done twice in triplicate. Statistical analysis was done 609 
with GraphPad Prism 5, using a Kruskal-Wallis test with a Dunns post hoc test. P-values ≤ 0.05 (*) and ≤ 0.01 (**) were considered 610 
significant. 611 
FIGURE 4: Butyrate and DL-lactate concentration after 24 h of in vitro fermentation of different substrates by A. butyraticus, L. 612 
crispatus and both in co-culture. The in vitro fermentation experiments were done twice in triplicate. Statistical analysis was done 613 
with GraphPad Prism 5, using a Kruskal-Wallis test followed by a Dunns post hoc test. P-values ≤ 0.05 (*), ≤ 0.01 (**) and < 0.001 614 







TABLE 1: The composition and nutrient content of the wheat/rye diet administered to chickens. Starter diet was given from day 1 2 
until 13, grower was given from day 14 until 26 and finisher was given from day 27 until 39.  3 
 Starter diet Grower diet Finisher diet 
Feedstuff (%)    
Wheat 44.00 46.51 49.78 
Rye 5.00 5.00 5.00 
Soybean meal (48) 23.30 19.78 16.61 
Soybeans 7.50 5.00 5.00 
Sunflower meal 27 2.50 2.50 2.50 
Rapeseed meal 7.50 10.00 10.00 
Animal fat 3.90 5.00 5.12 
Soy oil 2.80 2.82 2.61 
Vitamin + trace (vitamix) 1.00 1.00 1.00 
CaCO3 0.55 0.56 0.75 
Di-Ca-phosphate 0.90 0.62 0.37 
NaCl 0.21 0.21 0.19 
Na-bicarbonate 0.10 0.10 0.10 
L-Lys-HCl 0.14 0.15 0.20 
DL-Methionine 0.50 0.70 0.70 
L-Threonine 0.04 0.03 0.03 
Phytase 0.02 0.02 0.02 
Nutrient composition    
Crude protein (%) 23.00 21.50 20.50 
Crude fat (%) 10.23 10.66 10.91 
Non-soluble polysaccharides (%) 13.87 13.98 13.83 
Metabolisable energy (MJ/kg) 11.72 12.15 12.25 
D-Lysine (%) 1.12 1.03 1.00 
D-Sulfur amino acids (%) 1.10 0.77 0.75 
D-Threonine (%) 0.73 0.67 0.65 
D-Valine (%) 0.84 0.76 0.72 
Ca (%) 0.85 0.80 0.75 
Available P (%) 0.40 0.35 0.30 
NaCl + KCl (mEq/kg) 247 225 208 
Linoleic acid (18:2) (%) 3.34 3.15 3.17 
 4 
TABLE 2: The effect of XOS supplementation on the growth performance of the chickens. Feed conversion ratio (FCR), body 5 
weight (BW), feed intake (FI) and weight gain (WG) were measured at three time intervals for animals fed a wheat/rye-based diet 6 
without or with supplemented with 0.2% XOS (day 1-13) and 0.5% XOS (day 14-26; 27-39). Values are the mean of 6 pens with 32 7 
chickens ± standard error of the mean and n is the number of the chickens in each group. Statistical analysis was done with SPSS. 8 
 2
Independent samples t-test was used to determine statistical differences between groups receiving non-supplemented and XOS 9 
supplemented diet. P-values less than 0.05 and 0.001 were considered significant (*, **).  10 
Intervals in days  FCR BW (g) FI (g/d) WG (g/d) 
0-26 
-XOS 1.50 ± 0.01 1364 ± 15.39 67.3 ± 2.3 44,8 ± 1.50 
+ XOS 1.45 ± 0.01 1421 ± 16.97 69.4 ± 2.04 47,8 ± 1.72 
P-value P = 0.003 (**) P = 0.30 P = 0.50 P = 0.19 
0-39 
-XOS 1.66 ± 0.01 2401 ± 60.01 100.0 ± 2.75 60.4 ± 1.53 
+ XOS 1.63 ± 0.01 2446 ± 57.26 100.4 ± 2.43 61.6 ± 1.46 
P-value P = 0.04 (*) P = 0.60 P = 0.93 P = 0.60 
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TABLE 3: The effects of XOS supplementation on the intestinal morphology of chickens on day 26. The data shown are the mean 12 
length of the villi (µm) and mean thickness of the tunica muscularis (µm) in ileal sections taken at day 26 of animals fed a wheat/rye-13 
based diet, without or with supplemented with 0.5 % XOS (n=18). The length and the thickness were measured of 10 randomly 14 
selected villi and 10 different places for the tunica muscularis using a PC-based analysis system. Statistical analysis was done with S-15 
plus, using a linear mixed effects model with pen as random factor. P-value less than 0.05 were considered significant. 16 
 – 0.5% XOS + 0.5% XOS  
length of villi (µm) 1059 ± 40.00 1228 ± 59.79 P = 0.04  
thickness of tunica muscularis (µm) 167.0 ± 11.01 178.9 ± 6.32 P = 0.38 
 3
TABLE 4: List of Clostridium cluster XIVa and cluster IV members identified in the caeca of chickens at day 26 of which the relative proportion was significantly different between the XOS 17 
supplemented and unsupplemented group. The results are based on the sequencing data of 6 chickens per treatment (ns, not significant).  18 
 
   Highest 16S rRNA gene sequence similarity 
- 0.5 % 
XOS 
+ 0.5 % 
XOS P-value 
Type strain of validly named species (% 
16S rRNA gene sequence similarity) Accession number 
Clostridium cluster XIVa 29.64 44.29 0.004   
Blautia_RL199 0.04 0.15 0.04 Blautia faecis (95.96) DQ793371 
Lachnospiraceae_cc142 1.27 5.47 0.04 Blautia schinkii (93.93) DQ057372 
Lachnospiraceae_ic1296 0.34 0.79 0.03 Blautia producta (92.33) DQ057459 
Lachnospiraceae_GRC80 0.68 0.27 0.02 Eubacterium contortum (94.27) DQ673545 
Lachnospiraceae_B5-F3 1.19 7.28 0.01 Blautia producta (93.77) EF025241 
Lachnospiraceae_TS29 0.22 0.92 0.04 Eubacterium hallii (95.71) FJ367509 
Clostridium cluster IV 29.12 29.31 ns   
Ruminococcaceae_BY13 0.69 0.05 0.04 Pseudoflavonifactor capillosus (96.23) DQ342336 
Ruminococcaceae_CFT19C1 0.00 0.08 0.04 Clostridium alkalicellulosi (84.4) DQ455843 
Ruminococcaceae_CFT212F1
2 0.05 0.16 0.01 Oscillibacter valericigenes (95.73) DQ456381 
Ruminococcaceae_RL246 0.19 0.78 0.02 Clostridium alkalicellulosi (85.44) DQ793581 
Ruminococcaceae_TS1 1.78 0.29 0.03 Clostridium aldrichii (85.66) FJ365262 
Ruminococcaceae_ELU0008 0.04 0.30 0.01 Subdoligranulum variabile (92.69) HQ740050 
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